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Comparative genomicsThe characterization of complex diseases remains a great challenge for biomedical researchers due to the
myriad interactions of genetic and environmental factors. Network medicine approaches strive to accom-
modate these factors holistically. Phylogenomic techniques that can leverage available genomic data may
provide an evolutionary perspective that may elucidate knowledge for gene networks of complex dis-
eases and provide another source of information for network medicine approaches. Here, an automated
method is presented that leverages publicly available genomic data and phylogenomic techniques, result-
ing in a gene network. The potential of approach is demonstrated based on a case study of nine genes
associated with Alzheimer Disease, a complex neurodegenerative syndrome.
The developed technique, which is incorporated into an update to a previously described Perl script
called ‘‘ASAP,’’ was implemented through a suite of Ruby scripts entitled ‘‘ASAP2,’’ ﬁrst compiles a list
of sequence-similarity based orthologues using PSI-BLAST and a recursive NCBI BLAST+ search strategy,
then constructs maximum parsimony phylogenetic trees for each set of nucleotide and protein
sequences, and calculates phylogenetic metrics (Incongruence Length Difference between orthologue
sets, partitioned Bremer support values, combined branch scores, and Robinson–Foulds distance) to pro-
vide an empirical assessment of evolutionary conservation within a given genetic network. In addition to
the individual phylogenetic metrics, ASAP2 provides results in a way that can be used to generate a gene
network that represents evolutionary similarity based on topological similarity (the Robinson–Foulds
distance).
The results of this study demonstrate the potential for using phylogenomic approaches that enable the
study of multiple genes simultaneously to provide insights about potential gene relationships that can be
studied within a network medicine framework that may not have been apparent using traditional, single-
gene methods. Furthermore, the results provide an initial integrated evolutionary history of an Alzheimer
Disease gene network and identify potentially important co-evolutionary clustering that may warrant
further investigation.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Classical genetic diseases typically arise due to isolated genetic
changes within a single gene or allele [1]. Many of these ‘‘simple’’
or ‘‘monogenic’’ diseases follow Mendelian patterns of inheritance.The responsible genetic lesion is often the result of an insertion or
deletion event, or the transversion/transposition of a nucleotide.
The probability for transmission of simple genetic disorders may
thus be easily predicted and generally follow sex-linked or autoso-
mal patterns of heredity. Classic examples of monogenic disorders
include cystic ﬁbrosis, sickle cell anemia, and achondroplasia [2–
4]. By contrast, complex diseases or disorders may not follow clear
hereditary patterns or be diagnosed based on isolated genetic
lesions. However, many complex diseases such as cardiovascular
disease, type 2 diabetes mellitus, and Alzheimer Disease occur with
higher frequency among families and close genetic relatives – sug-
gesting that the interaction of genetic elements may play a central
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factors [5]. Identifying risks for complex diseases and developing
new approaches for treating or preventing them may beneﬁt from
high-throughput, computational, or bioinformatics based
approaches. Related advances in biotechnology have facilitated
the identiﬁcation of genotypes that may be factors involved in
the heritability of complex genetic diseases [6]. For example, speci-
ﬁc genotypes can be associated with a probabilistic value of sus-
ceptibility relative to the gene(s) they inﬂuence and thus
correlated with a disease phenotype [1,7–9].
Due to limited knowledge about the speciﬁc mechanisms by
which multiple genetic factors may inﬂuence complex diseases,
pharmacotherapies are often aimed at managing symptoms or
laboratory values, and are therefore reactionary and not preventa-
tive. Thus, the approach to complex disease management neces-
sarily extends beyond pharmacotherapy, attempting
environmental and behavioral changes through patient education
or lifestyle modiﬁcation [2,10]. A major current goal of biomedical
research is therefore to better characterize complex relationships
between contributing factors associated with complex diseases
for identifying possible targets for therapeutic intervention. Genet-
ic background inﬂuences the susceptibility to complex disease,
which is an artifact of the structural or functional relationships
between some or all members of a disease gene network [3,7].
These relationships may include direct physical interaction
between the protein products of the genes, parallel functionality
in metabolic pathways, or co-localization of protein products in a
certain cell or tissue type [4,7]. These data are not easily elucidated
using approaches that are focused on a single gene or pathway, and
instead require a broader systems-based methodology. Under-
standing the shared history of multiple genes may provide guid-
ance in developing approaches that target multiple genes that
have evolved to work together through evolutionary time.
Complicating the assessment of such systems-based method-
ologies is the lack of reference standards for benchmarking
approaches for discovering how myriad complex disease genes
work in the context of disease phenotypes. It should therefore be
noted that methodologies for interpreting multiple genes associat-
ed with complex disease may not quantiﬁably be benchmarked
against previously used methods that focus on single-gene analy-
sis. Instead, methodologies for multiple gene analysis can be seen
as identifying potential relationships between genes, necessitatingFig. 1. Overview of ASAP2 workﬂow. The process, as implemented in the study, begins w
reference resources like OMIM or other user chosen sequences. A combination of a high
similarity based orthologues (using a stringent E-value cutoff of 0.0). For each orthologue
based on metadata within the protein GenBank sequence. The remaining workﬂow foll
nucleotide sequence sets (called ‘‘partitions’’ in SA): Sequence Alignment (e.g., using MU
compared for each protein and nucleotide partition as well as for the overall protein o
(Multiple sequence alignment software). TNT: Tree analysis using New Technology (Mathe development of benchmarks and controls that can be per-
formed internally against known genetic interactions (and cases
where one can be fairly certain that no interaction is taking place).
Within the context of translational bioinformatics, there have
been a limited number of attempts to address understanding com-
plex diseases that accommodate multiple disease genes simultane-
ously. One method has described the use of Mendelian genetic
traits that occur in coincidence with complex genetic diseases to
predict underlying mechanisms of those diseases, primarily by
linking diverse biomedical databases [11]. Another approach
involves the linking of complex disease genes to other diseases
based on molecular similarity, which adapts a vector space model
approach [12].
Perhaps the most signiﬁcant approach developed to date for
studying the potential impact of multiple disease genes is that of
‘‘network medicine,’’ which systematically describes the rise of dis-
ease phenotypes as perturbations in the normal interactions of
molecular, environmental, and population networks rather than a
single macromolecule or biological pathway [13]. Network medi-
cine postulates relationships between genes based on observed
interacting phenomena, accounting for numerous genetic events
or environmental factors may contribute to similar phenotypic
results in one class of organism but not in another. Notably missing
from network medicine approaches to data is the inclusion of mod-
els that reﬂect evolutionary similarities between genes that com-
prise a disease network. Evolutionary models may provide a
perspective to the network medicine approach and enable the
inclusion of ancient environmental and population data into the
construction of a disease network and may identify both previous-
ly unknown factors contributing to disease development and new
model organisms for understanding disease pathology.
Phylogenetic analyses infer potential evolutionary relationships
based on similarities implying common descent from shared
ancestry and are performed on data sets consisting of physical,
functional, or molecular representations [14]. Genomic analyses
typically construct the analytic matrix using nucleotide or
amino-acid sequences from different individuals or species (ter-
med ‘‘taxa’’; singular ‘‘taxon’’). Classically, the resulting data are
presented as trees where the branching points (termed ‘‘nodes’’)
give rise to hierarchical groupings of more similar taxa (akin to
leaves on a branch). These trees can be used to explore potential
patterns of divergence from a common ancestor as well as theith the providing of GenBank IDs for protein sequences, which may originate from
ly speciﬁc recursive BLAST+ approach and PSI-BLAST is used to identify sequence-
protein sequence identiﬁed, its corresponding nucleotide GenBank entry is retrieved
ows the standard process for Simultaneous Analysis (SA) for both the protein and
SCLE) and phylogenetic tree building (e.g., using TNT). The resulting trees are then
r nucleotide SA tree. MUSCLE: Multiple Sequence Comparison by Log-Expectation
ximum Parsimony phylogenetic analysis software).
Table 1
The 10 genes originally selected for the Alzheimer Disease (AD) ASAP2 analysis.
Gene Common name GenBank GI GenPept GI
apbb2 Amyloid-B Precursor Protein-Binding Family B Member 2 225007611 50083291
nos3 Nitric Oxide Synthase 3 231571328 231571329
plau Urokinase-Type Plasminogen Activator 222537757 4505863
sorl1 Sortilin-Related Receptor L 307611954 4507157
a2m a-2-Macroglobulin 66932946 62088808
blmh Bleomycin Hydrolase 530411126 194378004
mpo Myeloperoxidase 4557758 4557759
ace Angiotensin I-Converting Enzyme 295844836 295844837
app Amyloid-b Precursor Protein 324021737 324021738
paxip1 PAX Transcription Activation Domain-Interacting Protein 1 – –
 Omitted from the study due to issues with recursive BLAST and PSI-BLAST search strategies.
Table 2
The 34 species identiﬁed by ASAP2 using Alzheimer Disease gene queries.
Scientiﬁc name Vernacular name NCBI Taxon
ID
Homo sapiens Human 9606
Pan troglodytes Chimpanzee 9598
Gorilla gorilla gorilla Western lowland gorilla 9595
Nomascus leucogenys Northern white-cheeked
gibbon
61853
Macaca mulatta Rhesus monkey 9544
Pan paniscus Bonobo 9597
Papio Anubis Olive baboon 9555
Callithrix jacchus White-tufted-ear marmoset 9483
Saimiri boliviensis
boliviensis
Bolivian squirrel monkey 39432
Mus musculus House mouse 10090
Otolemur garnettii Small-eared galago 30611
Pteropus alecto Black ﬂying fox 9402
Ovis aries Sheep 9940
Cavia porcellus Domestic guinea pig 10141
Sus scrofa Pig 9823
Rattus norvegicus Norway rat 10116
Bos Taurus Cattle 9913
Oryctolagus cuniculus Rabbit 9986
Ailuropoda melanoleuca Giant panda 9646
Tupaia chinensis Chinese tree shrew 246437
Felis catus Domestic cat 9685
Cricetulus griseus Chinese hamster 10029
Heterocephalus glaber Naked mole-rat 10181
Ceratotherium simum
simum
Southern white rhinoceros 73337
Orcinus orca Killer whale 9733
Odobenus rosmarus
divergens
Paciﬁc walrus 9708
Dasypus novemcinctus Nine-banded armadillo 9361
Chinchilla lanigera Long-tailed chinchilla 34839
Ictidomys tridecemlineatus Thirteen-lined ground squirrel 43179
Trichechus manatus
latirostris
Florida manatee 127582
Mustela putorius furo Domestic ferret 9669
Condylura cristata Star-nosed mole 143302
Octodon degus Degu 10160
Jaculus jaculus Lesser Egyptian jerboa 51337
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difference is usually described as an evolutionary ‘‘distance’’ that
can be inferred multiple ways, but typically represents a measure
of evolutionary change (based upon sequence differences) or an
amount of time since divergence likely occurred [15,16].
However, like experiments focused on a single gene or pathway,
an isolated phylogenetic analysis may not capture important fea-
tures of co-evolution or conservation of gene clusters impacting
complex disease processes. Additionally, reliance on phylogenetic
trees of individual genes may not fully address the potential for
genetic changes such as lateral gene transfer, reversion of muta-
tions, or recombination events [17,18].To account for multiple evolutionary patterns represented by
multiple genes, data matrices can be combined into a single phylo-
genetic analysis through a ‘‘simultaneous analysis’’ (SA) approach
[19–21]. In SA, individual data blocks (e.g., a sequence matrix for
a particular gene; referred to as a ‘‘partition’’) are systematically
combined to enable higher-order analyses that transcend data
derived from analysis of an individual partition. Frequently, SA val-
ues are derived by applying arithmetic operations on other
(already determined) SA values, so the workﬂow tends to follow
a stepwise pattern. SA techniques have been shown to strengthen
the overall support for the evolutionary patterns represented by
trees determined by single partition phylogenetic analyses [22].
However, while the aforementioned network medicine approach
aims to examine relationships between multiple genes simultane-
ously, there has been no direct incorporation of phylogenetic met-
rics, such as those that result from a SA, in the study of disease
genes. There is thus a signiﬁcant opportunity to explore the poten-
tial utility of SA techniques in light of network medicine approach-
es towards the ultimate goal of developing a multi-faceted
perspective of the evolution and interaction of disease genes.
This study aimed to explore the potential of leveraging SA tech-
niques for providing additional information that can be used with-
in a network medicine context. The approach builds on the notion
that evolutionarily signiﬁcant types of relationships may be identi-
ﬁed using phylogenetic techniques within the genetic context of a
given complex disease [5,39,40]. In particular, this study sought to
explore the relative evolutionary conservation of nine genes asso-
ciated with Alzheimer Disease (AD). The potential meaningfulness
of the suggested evolutionarily similar relationships is gauged rela-
tive to both sets of genes that are known to be highly correlated
(mitochondrial genes) and non-correlated (randomly selected
genes from different, unrelated diseases). Furthermore, the relative
co-evolution of AD disease genes was gauged relative to those
genes that have been previously identiﬁed as being uniquely asso-
ciated with AD versus those that are more polygenic. The promis-
ing results of this feasibility study suggest that phylogenetic
approaches that can incorporate information from multiple genes
may offer evolutionary insights into complex disease gene rela-
tionships. The results further suggest that disease genes that are
unique to a single disease may have a relatively conserved evolu-
tion across orthologues across evolutionary time compared to
those that are shared with other diseases.2. Materials and methods
2.1. Overview
The overall goal of this study was to develop an automated
method for an SA phylogenetic analysis and to use it to construct
an evolutionary history for a set of genes that may be correlated
(a) a2m
Fig. 2. Individual nucleotide trees. Nucleotide trees are shown for each Alzheimer Disease gene included in this study, which show the drastic topological differences between
individual AD nucleotide phylogenies within the AD gene network. Multiple taxa from the same taxonomic order are accordingly colored (Red = Primates, Blue = Rodentia,
Green = Artiodactyla, Pink = Carnivora). Each tree is presented as a sub-ﬁgure, with the name of the human gene in the upper-left corner. Yellow highlighted region in (c)
emphasizes the only instance of polytomy in the AD nucleotide trees. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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context. AD was chosen as a case study because it has that distinct
genes have been identiﬁed previously to correlate strongly with
formation of the disease, which is a likely artifact of the fact that
AD is a popular complex disease to study. Co-evolutionary patterns
were examined for nine of these genes using a SA technique medi-
ated by a series of scripts written in the Ruby scripting language.
The resulting phylogenetic tree provides the ﬁrst description of
the co-evolution of genes within a network medicine framework
that may reveal the development and pathogenesis patterns of
AD. The developed technique provides a framework for an auto-
mated approach to study the co-evolution of gene sets associated
with a complex disease using a robust phylogenetic methodology.
In this study, a previous automated SA approach (Automated
Simultaneous Analysis Phylogenetics; ASAP [41]) was both reﬁnedand expanded upon to collect and analyze disease genes based on:
(1) the degree of corroboration between partitions; and (2) the
support for an overall consensus tree modeling a putative evolu-
tionary relationship common to all partitions, using maximum par-
simony analysis [42]. The ﬁnal phase then generates a gene
network based on the Robinson–Foulds tree similarity metric
[43]. The original ASAP began with a set of given completed data
partitions, which would then be aligned, subjected to maximum
parsimony phylogenetic analyses that resulted in the reporting of
accepted simultaneous analysis support values. ASAP2 includes
many of the features of ASAP, but also is able to automatically con-
struct data partition from a set of query genes, perform data parti-
tion homogeneity tests (the Incongruence Length Difference [ILD],
described below) and calculate Robinson–Foulds topology dis-
tances between trees. An added beneﬁt of ASAP2 is that it utilizes
(b) ace
Fig. 2 (continued)
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of PAUP⁄) and provides a more general implementation of SA that
could be used in the context of traditional multi-gene analyses or
to speciﬁcally enable the analysis of complex disease genes, such
as presented here.
The automated collection and simultaneous phylogenetic ana-
lysis process was developed using a sequential set of Ruby [44]
scripts (entitled and referred to henceforth as ‘‘ASAP2’’ – DOI:
http://dx.doi.org/10.5281/zenodo.11075) that made use of the
Bioruby gem [45] as well as the following freely available genomic
or phylogenetic analysis tools: BLAST+ (Basic Local Alignment
Search Tool [46]), MUSCLE (MUltiple Sequence Comparison by
Log-Expectation [47]), and TNT (Tree analysis using New Tech-
nology [48]). The overall workﬂow for ASAP2 is shown in Fig. 1.
From a technical perspective, ASAP2 is an improvement over an
earlier version of the implemented approach (ASAP, which was
written as a single Perl script) both in terms of modularity and
use of contemporary phylogenomic tools.2.2. Alzheimer Disease gene sequences
Nucleotide sequences for genes implicated as contributing to a
higher risk for Alzheimer Disease (AD) in humans were manually
identiﬁed using the data associated with the ‘‘Alzheimer Disease;
AD’’ entry in Online Mendelian Inheritance in Man (OMIM) (OMIM
ID #104300) [49]. This yielded ten discrete genes shown to be
related to AD, which were loaded into ASAP2. For the purposes of
this study, nonspeciﬁc chromosomal regions that encompass
numerous genes or the noncoding regions between them were
not included.
2.3. Identifying potentially related disease genes based on sequence
similarity
From the initial set of human AD disease gene sequences, ASAP2
performed two types of sequence searches from within the non-re-
dundant (nr) protein database maintained at the United States
(c) apbb2
Fig. 2 (continued)
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Information (NCBI) using NCBI BLAST+ [46]. First, a PSI-BLAST
(Position-Speciﬁc Iterated BLAST) search (which searches for simi-
lar sequences using an iterative proﬁling approach [50]) was done
for each gene sequence. Second, a recursive search was initiated
with a BLASTx (which uses a translated nucleotide sequence query
to perform a protein search) search of the nr protein database for
the gene of interest and the best results used to iteratively search
for additional protein sequences using BLASTp (which searches for
protein sequences using an amino-acid query) until no additional
sequences were found. An expect value (E-value) of 1.0  10256
was used as the criterion for inclusion of results for both the PSI-
BLAST and the recursive BLAST algorithm. Candidate data partition
matrices for each gene were then constructed based on the combi-
nation of PSI-BLAST and recursive BLAST results. Corresponding
nucleotide sequences were determined based on information in
the DBSOURCE metadata ﬁeld that links a given protein sequence
to its coding nucleotide sequence.
After candidate data partitions were assembled, ASAP2 culled
taxa and sequences from each data partition that were notuniformly represented for each gene (i.e., a sequence for a given
species must be present in each data partition for that species to
be retained for further analysis). Additionally, if any species was
represented more than once in any partition, ASAP2 only kept
the ﬁrst (most similar according to BLAST) protein sequence for
that species. ASAP2 then assembled the resulting data partitions
into FASTA ﬁles, aligned them using the default parameters of
MUSCLE, and formatted them into TNT-compatible data matrix
ﬁles. ASAP2 also includes the ability to align sequences using
MAFFT or Clustal Omega, which are packaged alongside MUSCLE
and may be speciﬁed using arguments at runtime. Additionally,
the user has the ability to provide sequences aligned through
other means (including manually). For the purpose of this study,
and to demonstrate the automated capabilities of ASAP2, all
sequences were aligned using the default MUSCLE strategy. The
generated FASTA ﬁles and TNT data matrix ﬁles are available as
Supplementary Data.
In order to conﬁrm that only relevant sequences were identiﬁed
by the BLAST search strategy, the description of each identiﬁed
sequence was manually inspected to ensure that it was appropriate
(d) app
Fig. 2 (continued)
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of the GenBank entry was not informative, further manual investi-
gation of the sequence was performed (e.g., inspection of the
sequence alignment).
Sequence length was manually veriﬁed following the selection
of sequences, prior to conducting simultaneous analysis. As the
SA techniques implanted in ASAP2 do not require a distinction
between orthologues and paralogues, this was done only with
the intent of preventing the use of large chromosomal assemblies
or very short gene fragments. Additionally, the BLAST2 expect val-
ue between each pair of sequences in each partition was computed
to verify that all sequences are statistically similar to one another;
No maximum expect value was used as a cutoff, but all values were
smaller than 1  10100.
2.4. Phylogenetic analyses
ASAP2 used TNT to conduct the maximum parsimony phyloge-
netic analyses of each data partition. Trees were constructed usingtree bisection and reconnection (TBR) rearrangement, ﬁnding opti-
mal scores 20 times followed by 10 cycles of tree-drifting. Subse-
quently, group support values were determined by counting the
minimum number of steps needed to lose each group by TBR rear-
rangement [51]. The TNT analysis included individual plotting of
apomorphies and synapomorphies, bootstrap resampling, and cal-
culation of both the relative and absolute Bremer support values at
each branch.
ASAP2 then generated a SA consensus tree using TNT by creat-
ing an interleaved matrix of the data partitions. The interleaved
matrix was built by concatenating each aligned data partition
(minus headers and metadata) sequentially, separated by line
breaks, into a single TNT data ﬁle. This data ﬁle was then interpret-
ed by TNT as if the sequences for each species were concatenated
in the order of the data partitions in the interleaved matrix. The
tree building routine was the same as used for analyzing the indi-
vidual data partitions, except 30 cycles of tree-drifting were used.
The Partitioned Bremer Support (PBS; also known as Partitioned
Branch Support) at each node in the SA consensus tree was used as
(e) blmh
Fig. 2 (continued)
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PBS value is deﬁned as ‘‘the minimum number of character steps
for [a] partition on the shortest topologies for the combined data
set that do not contain that node, minus the minimum number
of character steps for that partition on the shortest topologies for
the combined data set that do contain that node’’ [20]. Therefore,
a speciﬁc PBS value can be interpreted as a measurement of how
well the data from a particular partition either support (represent-
ed by positive values) or refute (negative values) a particular node
on the consensus tree. Branch Support (BS) values, deﬁned as ‘‘the
minimum number of character steps for that data set on the short-
est topologies that do not contain that node, minus the minimum
number of character steps for that data set on the shortest topolo-
gies that contain that node’’ were used as the second criterion for
evaluation of the SA consensus tree [20]. After determining PBS
values across all tree nodes on the consensus tree for each data
partition, the BS was determined for each node on the consensus
tree by the sum of all PBS values for that particular node. A positive
BS score indicates that the overall combined set of data partitions
support the topology at that node rather than refute it. ASAP2 usesa slightly modiﬁed version (for the purpose of automation) of a
previously developed TNT script to calculate the PBS values [52].
Modiﬁcations were made to the original TNT script were to facili-
tate automated data input and processing of output as required by
ASAP2 without altering the tree building routines, and minimizing
the text-based front end displayed to the user.
The Hidden Branch Support (HBS) for a particular node on the
consensus tree was computed as the difference between the BS
value at that node in the consensus tree and the sum of the BS val-
ues for that node from each data partition. The magnitude of an
HBS value of a given node in the consensus tree was used as the
ﬁnal criterion for determining the overall strength of supporting
or refuting the topology at the node.
Finally, a gene network was generated from the consensus ana-
lyses for each data partition using the Robinson–Foulds (RF) metric
to quantify the distance between each pair of trees [43]. This was
implemented using a previously written TNT script [53] that was
modiﬁed to ﬁt within the automated workﬂow of ASAP2. All calcu-
lations and parameters in the script were unchanged from the ori-
ginal version. To transform RF values onto a scale where larger
(f) mpo
Fig. 2 (continued)
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values indicate greater dissimilarity based on a normalized count
of symmetric differences between trees), the following calculation
was used:
RF 0 ¼ 1
eRF
Cytoscape [54] was then used to visualize the gene network that
was based on the RF0 values as normalized edge weights using a
force-directed layout.2.5. Compatibility and homogeneity testing of partitions
The Incongruence Length Difference (ILD) test [55] was used to
quantify the combinability of the data partitions, which is a statis-
tical measure that is commonly employed in Maximum Parsimony
analyses. The ILD test compares the difference in length of the best
tree for each individual partition with the best tree for all data par-
titions concatenated into a single block, and then performs thesame calculation for a large number of random partitionings of
the same data.2.6. Establishing a benchmark for ASAP2
ASAP2 was run using the mitochondrial genes for the 34 species
included in the AD study, where the data partitions were con-
structed from the protein and translated nucleotide sequences
for mtDNA genes. The gene clustering diagrams based on the RF0
values for the mtDNA analysis were viewed individually, and again
when ASAP2 was run using the gene partitions from both the AD
study and the mtDNA genomes. Comparison of the relative RF0
scores was facilitated through a visual comparison of the diagrams
to qualitatively interpret the strength of the conclusions made by
the AD analysis alone.
Following this benchmark of mtDNA genes (which were pre-
sumed to be conserved over evolutionary time), ASAP2 was run
again using a set of genes that each affect susceptibility to different
complex genetic disorders, aiming to explore any potential
(g) nos3
Fig. 2 (continued)
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mtDNA analysis, the results were interpreted based on RF0 scores
relative to the nine AD genes and also facilitated by visual compar-
ison of the generated diagrams.
Finally, to calibrate the results of the analysis of eight random
genes against the set of nine AD genes initially used, ASAP2 was
run using the union of the two sets of data partitions, which totaled
16 partitions. Since ASAP2 requires all partitions to contain the
same set of taxa, the intersection of species across both sets of par-
titions was used.3. Results
3.1. ASAP2
ASAP2. was developed as a set of Ruby scripts and is available at
GitHub under the GNU General Public License (https://github.com/
UVM-BIRD/asap2 [DOI: http://dx.doi.org/10.5281/zenodo.11075]).
The script guides the process of performing a SA from an initial
set of Genbank identiﬁers. By the end of the analysis, ASAP2 pro-duces ﬁles containing the data partitions, E-value tables, FASTA
ﬁles of the ﬁnal data partitions (both unaligned and aligned),
TNT data matrices, and all TNT output, including log ﬁles and par-
enthetically-notated tree ﬁles. The ASAP2 data workﬂow is illus-
trated in Fig. 1.3.2. Gathering uniform taxonomic distribution of AD genes
Ten genes associated with Alzheimer Disease susceptibility
were initially selected through OMIM for analysis using ASAP2.
Due to incompatibility issues with BLASTx, one gene (PAX-inter-
acting protein 1 [PAXIP1]; GI:530387259) was removed from the
analysis. In brief, because PAXIP1 contains six BRCT (BRCA C termi-
nus) domains that are homologous to many sequences in GenBank,
BLASTx quit at each attempt due to memory overﬂow. The nine
remaining genes used for the remainder of the study are listed in
Table 1.
The combined PSI-BLAST and recursive BLAST results for each
gene included in this study resulted in nine data partitions repre-
senting 34 unique species (including Homo sapiens; Table 2). If
(h) plau
Fig. 2 (continued)
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than once in a data partition, only the ﬁrst sequence (the one most
similar to the query sequence) was kept. The protein sequences
identiﬁed – along with the corresponding source nucleotide
sequences – using this process are provided in Supplementary
Table 1.
3.3. Incongruity of AD data partitions
The p-values for the ILD test between each of the nucleotide and
protein data partitions are listed in Tables 5 and 6, respectively. All
p-values were 0.01, with the exception of the a2m/plau nucleotide
data comparison, indicating very high degrees of incongruence.
Likewise, performing the ILD test on the complete concatenation
of all nine nucleotide and all nine protein data partitions yielded
p-values of 0.01. Such highly incongruent data partitions were
expected, since the goal of the study was to highlight and inspect
variations between MP analyses over the same set of species.
3.4. Simultaneous analysis
All phylogenetic analyses were rooted to Dasypus novemcinctus
(nine-banded armadillo), which was determined to be the furthestdiverged from humans using TimeTree [16]. Individual maximum
parsimony trees for each nucleotide and protein data partition
are shown in Figs. 2 and 3, respectively. Consensus SA trees based
on the combination of the nine data partitions are shown in Figs. 4
and 5 (nucleotide and protein tree, respectively). Computed Branch
Score (BS) values are shown on the consensus trees, and corre-
sponding Partitioned Bremer Support (PBS) values are listed in
Tables 3 and 4, respectively.
Each of the SA trees showed a distinct branching pattern, with
all parent nodes on all trees strictly bifurcating. Furthermore, while
some PBS values were negative (indicating that the data in a speci-
ﬁc partition was not congruent with the consensus tree at that
branch), all the BS values on the protein SA tree were positive.
The nucleotide SA tree had positive BS scores at each node with
no polytomies, suggesting that the genes selected for this study
supported all the internal branches in the protein simultaneous
analysis tree.
While the topologic organization of the SA trees generally fol-
lowed canonical patterns of mammalian evolution there were
some notable exceptions that received high levels of statistical
support. In the SA nucleotide tree, most primates were grouped
together into the monophyletic clade rooted at node 13, with the
exception of Macaca mulatta (rhesus macaque), Callithrix jacchus
(i) sorl1
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galago) that each occurred distally from all other primates
(Fig. 4). In the SA protein tree, primates were divided into two dis-
tinct clades: (1) a monophyletic clade rooted at node 27, or (2) a
paraphyletic clade rooted at node 8 that also included Sus scrofa
(wild boar) and Jaculus jaculus (lesser Egyptian jerboa) (Fig. 5).3.5. Comparison of trees using the Robinson–Foulds metric
The Robinson–Foulds metric was used to quantify the similarity
between the generated trees. The pairwise comparisons between
each of the nucleotide and protein data partitions are shown in
Tables 5 and 6, respectively. Additionally, the RF0 distances for
respective nucleotide and protein trees for a given partition as well
as for the SA trees are shown in Table 7. The RF0 distances were
used as input into CytoScape to visualize the relative relationship
between both the nucleotide and the protein sequences for a given
gene based on shared evolutionary history, shown in Fig. 6A
(nucleotide sequences) and Fig. 6B (protein sequences). The result-ing gene networks showed a tight clustering of MPO, A2M, NOS3,
SORL1, and PLAU evolutionary patterns.3.6. Comparison of AD gene clustering to mtDNA genes
A benchmark for ASAP2 was accomplished by comparing the
results for the set of AD genes to the corresponding results using
sequences for mtDNA genes for the same set of 34 taxa. The RF0
gene clustering network diagrams (Fig. S1a for nucleotide
sequences and Fig. S1b for protein sequences) for the mtDNA genes
alone show relatively tight clustering, with the slight exception of
the ND4L gene in the protein analysis and the ND6 gene in the
nucleotide analysis. Overall, this ﬁnding recapitulates that mtDNA
genes may be suitable as taxonomic markers or for species identi-
ﬁcation. When both mtDNA and AD gene partitions were used
simultaneously in ASAP2 (Fig. S1c and S1d, for nucleotide and pro-
tein sequences, respectively), the network diagrams reveal that the
mtDNA genes cluster closely with a number of AD genes that
(a) A2m
Fig. 3. Individual protein trees. Protein trees are shown for each Alzheimer Disease gene included in this study, which show the drastic differences between the individual AD
protein phylogenies. Additionally, the high incidence of polytomies demonstrates the difﬁculty in resolving meaningful phylogenies for highly-conserved protein sequences.
Multiple taxa from the same taxonomic order are accordingly colored (Red = Primates, Blue = Rodentia, Green = Artiodactyla, Pink = Carnivora). Each tree is presented as a
sub-ﬁgure, with the name of the human gene in the upper-left corner. Red arrow in (d) indicates the node with the highest degree of polytomy in this study (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.).
22 J.D. Romano et al. / Journal of Biomedical Informatics 54 (2015) 10–38themselves form a cluster – namely MPO, A2M, NOS3, SORL1, and
PLAU.
Additionally, the SA trees (Supplementary Data) for the mtDNA
analysis demonstrated a striking departure from the topology
shown in the AD SA trees. In agreement with mtDNA genes being
highly conserved throughout the tree of life, trees constructed from
mtDNA gene sequences closely resemble the actual evolutionary
histories of the species in the trees [56], while the AD SA trees
exhibited striking departures from the expected topology. This
strengthens the proposition that abnormal patterns of evolution-
ary conservation may help distinguish and characterize the mole-
cular basis of complex genetic diseases. These promising ﬁndings
suggest that future work is needed to include the use of ASAP2
to study additional complex diseases, which will help further vali-
date the methodology proposed here as well as better support the
proposed ﬁndings relative the AD genes included in this study.3.7. Benchmarking ASAP2 using randomly selected query genes
A second benchmark was established by running an ASAP2 ana-
lysis against eight randomly selected genes, each of which is impli-
cated in susceptibility to a different complex genetic disorder
(Table 8). In searching for non-human sequences corresponding
to these eight genes, a different set of species was identiﬁed, each
member of which possesses at least one putative orthologue to
each of the human query genes. The RF0 values generated using
both the protein and translated nucleotide sequences demonstrat-
ed far less conservation of a common evolutionary pattern than
with the AD analysis. Whereas the AD nucleotide analysis resulted
in RF values ranging from 0.750 to 0.969 (mean: 0.907 ± 0.055), the
analysis of the benchmark of eight randomly selected genes
resulted in RF values (Table 9) ranging 0.877–0.970 (mean:
0.952 ± 0.026). Likewise, the AD protein analysis resulted in RF
(b) Ace
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the analysis of the benchmark of eight randomly selected genes
resulted in RF values (Table 10) ranging 0.895–0.968 (mean:
0.944 ± 0.025). Larger RF distances indicate more highly dissimilar
trees, corresponding to less evolutionary conservation. Overall, this
demonstrates a higher degree of variability in the AD analysis,
which corroborates the claim that certain members of the AD gene
family have been conserved together over evolutionary time.
As with the AD analysis, force-directed graphs of the RF results
were generated for both the nucleotide (Fig. S2a) and protein
(Fig. S2b) data partitions in the benchmark. However, the graphs
for the benchmark analysis do not adequately demonstrate a lack
of clustering as would be expected by the numerical data. This is
due to the graph being projected onto a 2-dimensional plane,
resulting in an apparent distortion of some of the edge lengths.
Regardless, the numerical data show a distinct pattern of large RF
distances between trees, as opposed to the formation of tight‘‘clusters’’ within the AD and mtDNA analyses, which strongly sup-
ports the hypothesis that these ‘‘clusters’’ predict a close functional
relationship between certain genes in the given framework.
When ASAP2 was run using the union of all AD data partitions
and the eight randomly-selected data partitions (full data avail-
able in Supplementary Data), the resultant force-directed graphs
of RF0 distances (Fig. S2c and S2d) depicted the AD genes as a
distinct set segregated within the graph, forming another tight
‘‘cluster’’ among the sparsely located random genes. These
observations suggest that the results of the AD analysis cannot
be quantitatively compared against the random gene analysis
when they are run separately (due to support values being
relative). Additionally, this suggests that ASAP2 may be used as
a potential as a tool for identifying complex disease genes that
have a shared history, in addition to being useful for analyzing
relationships within an already known network of shared
phenotypic functionality.
(c) Apbb2
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Alzheimer Disease (AD), a complex neurodegenerative disorder,
is the most common form of dementia, accounting for between
70% and 90% of diagnosed cases of dementia [23,24]. Worldwide,
more than 24 million people are estimated to have AD, with esti-
mates exceeding 80 million to be affected over the next 30 years
[25]. The pathognomonic histological ﬁnding that originally
deﬁned AD is the presence amyloid plaques in cortical brain tissues
[26–28]. The plaques arise from the production, and eventual
extracellular precipitation, of ﬁbrillar aggregates of amyloid-b pep-
tides causing disruption of the neural architecture and induction of
inﬂammation [26]. Clinically, AD is characterized by progressive
memory loss and cognitive decline, leading to general functional
impairment [27–32]. However, the precise etiology of AD remains
elusive. Amyloid plaques have been shown to differ widely in
manifestation with regards to protein composition, structural
characteristics, and prevalence [33,34]. Despite advances in pre-
dicting the presence of the disease based on symptoms and diag-
nostic imaging, a deﬁnitive diagnosis of AD can only be madeafter an autopsy of the affected brain after death [29,30]. As such,
researchers are faced with signiﬁcant difﬁculties both in studying
the progression of the disease as well as identifying potential
therapeutic techniques to prevent or treat the disease.
Further compounding the difﬁculty in identifying causes of AD
is the fact that the majority of cases do not follow a well-character-
ized pattern of heritability, even though susceptibility to AD is
widely considered to have a genetic basis [33,35–37]. Familial
forms of AD have been identiﬁed resulting from single or double
gene lesions leading to increased amyloid plaque burden, but these
account for less than 5% of the total cases of AD [38]. A wide range
of human genes have been linked to susceptibility at various stages
of life, suggesting sporadic AD has a multifactorial, complex genet-
ic component [38]. The complex, multi-gene aspect of AD, taken in
combination with the potential impact of shared evolution of its
associated genes offers an excellent candidate disease to explore
the potential utility of SA techniques.
The use of ASAP2 enabled the generation of a ﬁrst view of a gene
network based on an integrated phylogeny of AD-associated genes.
The results suggest that SA techniques may have utility in the
(d) App
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aim to model the evolutionary development, transmission, and
interaction of disease associated gene sets. As a new paradigm
for studying complex disease genes, the network approach pre-
sented here relies on the assumption that individual genes may
indeed diverge substantially from what one might expect at the
species level. Indeed, the Incongruence Length Difference (ILD) test
indicates that, in a conventional phylogenetic analysis, the AD
genes used here should not be used to impute traditional hypothe-
ses of species-level evolution. However, individual gene phyloge-
nies may provide unique information about the functionality of
the genes from which they are constructed relative to the associat-
ed disease within a network medicine context. Thus, a combined
analysis of complex disease genes, which may be counter-intuitive
from traditional phylogenetic practices (where genes are generally
only be combined when reﬂecting common topologies), can be
used to identify potential shared evolutionarily shared relation-
ships that would otherwise not be discovered. The divergences
from conventional phylogenetic analyses make the methodology
described in this study particularly amenable to network analyses,
where the correlations and relations are based on overalltopological similarity that reﬂect concordance of evolutionary
patterns across multiple genes for a common set of taxa.
4.1. ASAP2 function
ASAP2 consolidates a set of phylogenetic techniques into a sin-
gle pipeline of Ruby scripts designed to expose higher-order quan-
titative relationships between genes not visible through more
traditional single-gene based analyses. Implementing phylogenetic
techniques often requires a signiﬁcant amount of manual data
curation that is both labor- and time-intensive, especially in the
context of disease genes. ASAP2 was designed as a ﬂexible auto-
mated tool that performs these tasks with minimal required inter-
vention beyond entering an initial set of GenBank identiﬁers.
ASAP2 thus supports the ability to do large-scale phylogenetic ana-
lyses in a tractable manner. ASAP2 execution time is generally
H(n2) with respect to both the number of data partitions and the
average length of sequences, but overall runtime can be consider-
ably reduced based on available computational resources for indi-
vidual BLAST queries, sequence alignments, and phylogenetic tree
search routines. The data structures produced by ASAP2 were
(e) Blmh
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analysis. This supports the ability to adjust subsequent analyses
based on results generated at any point along the analysis pipeline.
It is important to note that orthology determination based on
sequence similarity alone may result in unexpected sequences
being included in an analysis (e.g., it has been shown sequence
similarity methods such as BLAST do not always return the closest
related sequences [57]. To address this potential issue, ASAP2
enables the user to create a set of data partitions using their own
preferred search strategy. Nonetheless, in this feasibility study that
focused on AD genes, it was felt that it would be of utility to
demonstrate the potential of an automated search strategy, as both
a proof of concept and as a means to standardize the selected
orthologues. The selected putative orthologue sequences were
manually veriﬁed to ensure that no irrelevant sequences were
introduced into a given data partition. Uniformly across the AD
analysis, no sequences identiﬁed using the described BLAST algo-
rithm were found to be irrelevant in the scope of their respective
query sequences.The original Perl version of ASAP [41] required a prior ﬁle con-
taining sequences that was then aligned using MUSCLE and the
phylogenetic analysis was subsequently executed using PAUP⁄
[58]. ASAP also allowed for the inclusion of pre-aligned or morpho-
logical data. By contrast, ASAP2 was developed in Ruby, and uses
MUSCLE based alignment with the subsequent phylogenetic ana-
lyses done in TNT (which is freely licensable, unlike PAUP⁄). Addi-
tionally, ASAP2 was speciﬁcally designed to work exclusively with
molecular data available from GenBank/GenPept, requiring only
that the user provide an initial set of Accession numbers.
In this study, the utility of ASAP2 was demonstrated by per-
forming analyses on a discrete set of pre-identiﬁed sequences
within the context of developing a gene network to enhance net-
work medicine knowledge for disease genes. However, the script
may also be used for a number of large-scale multi-gene phyloge-
netic investigations. For example, one could use ASAP2 to study
whole genomes with the goal to identify essential, evolutionarily
conserved genes in groups of species [9,21]. Conceptually, by
adjusting inclusion thresholds for the BLAST search mechanism
(f) Mpo
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procedure, analyses could be expanded for constructing SA net-
works with respect to entire gene families.
Although this study made speciﬁc use of MUSCLE for multiple
sequence alignment, ASAP2 includes the ability to alternatively
use MAFFT or Clustal Omega. It should be noted that it might be
possible for future versions of ASAP2 to include the ability to per-
form phylogenetic analyses within a maximum likelihood frame-
work, although the majority of simultaneous analysis methods to
date have relied upon maximum parsimony, and new methods of
computing SA values would need to ﬁrst be devised that are analo-
gous to the ones used in maximum parsimony (e.g., for assessing
deviations from actual evolution).
4.2. Putative orthologue sequence identiﬁcation
Based on an initial OMIM query for Alzheimer Disease, ortho-
logues for 34 species were identiﬁed across nine disease genes.
In addition to the recursive BLAST based approaches implementedby ASAP2, there are speciﬁc orthologue resources that could have
also been searched to identify orthologous sequences for each of
the nine disease genes. For example, inParanoid [59] and
OrthoMCL [60] had eight and 13 species spanning the nine genes,
respectively. Interestingly, in identifying the set of species that
contains putative orthologues for each of the AD genes through
each of the three identiﬁcation methods, ASAP2 and inParanoid
identiﬁed only mammalian species, while OrthoMCL identiﬁed a
set of organisms that included several non-mammalian species,
including Danio rerio (zebraﬁsh), Takifugu rubripes (tiger blowﬁsh),
Tetraodon nigroviridis (spotted green pufferﬁsh), and Gallus gallus
(chicken). Additionally, both inParanoid and OrthoMCL identiﬁed
the species Canis familiaris (dog) and Equus caballus (horse), while
ASAP2 did not. The differences in orthologue identiﬁcation may
be due to the conservative ﬁltering parameters used for BLAST
queries in ASAP2 that were tuned to ensure a high degree of simi-
larity between sequences and to minimize the possibility of ran-
dom homologies (as implicated by using an E-value of
1.0  10256). Neither inParanoid nor OrthoMCL identiﬁed the
(g) Nos3
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focus of this study. ASAP2 does allow for the inclusion or removal
of sequences to increase or reduce the taxonomic diversity of a
given analysis immediately following the BLAST analyses; howev-
er, since no additional taxa were identiﬁed uniformly across the
nine genes of interest by either OrthoMCL or inParanoid, no such
modiﬁcation of taxon diversity was performed in this study. Addi-
tionally, future studies may beneﬁt from starting with a wider
empirical set of genes or with parameters for the recursive BLAST
strategy that are tuned to higher E-values that could lead to greater
taxonomic diversity.
The ASAP2 sequence identiﬁcation method does not have the
ability to deﬁnitively distinguish between orthologues and par-
alogues. Distinguishing between the two is an ongoing challenge.
However, due to the low expect value currently used in the ASAP2
BLAST search strategy, only highly similar sequences are preserved
(and, if more than one sequence is found for a given species, only
the ‘best’ sequence will be kept). Therefore, regardless of whether
an identiﬁed sequence is an orthologue or an in-paralogue to a
human sequence, the phylogenetic analysis of the sequencesshould reveal how that sequence has evolved across the set of spe-
cies. In this way, ASAP2 provides a systematic mechanism to lever-
age both similarity-based approaches for sequence identiﬁcation
alongside phylogenetic approaches for evolutionary study of those
similar sequences.
4.3. Phylogenetic analysis
The individual gene genealogies returned by the phylogenetic
analyses of individual gene partitions were not expected to imply
speciation or speciﬁc transmission of genetic elements. ‘‘Evolution-
ary conservation’’ of certain groups of genes in this study refers to
the conservation of gene function within a constrained group of
other genes. Effectively, these individual phylogenies highlight
constrained variations in the genome that are at a number of mag-
nitudes higher resolution than easily discernable traits, with the
exception of disease phenotypes arising due to a malfunction with-
in the given set of genes.
The TNT analyses used by ASAP2 were optimized to only
include the most unambiguous groupings. As such, the TNT scripts
(h) Plau
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lutionary history is correspondingly more reliable. The ﬁnal con-
sensus tree represents a likely model of evolutionary
transmission of the group of Alzheimer Disease genes studied,
and the partitioned Bremer support values indicate the degree to
which each gene ﬁts the predicted pattern of evolution. The parti-
tioned Bremer values may also be used to identify genes or species
in a study that did not (for one reason or another) follow a similar
pattern of transmission as the others. Topologically, the SA protein
tree in this study exhibited a small number of groupings that differ
from the accepted model of mammalian evolution, notably the
separation of primates into two distinct clades (Fig. 5, highlighted
in yellow). On the SA nucleotide tree, the paraphyletic grouping of
some primates (Fig. 4, highlighted in yellow) also merits scrutiny
since this suggests that the genes included in this study deviate
from taxonomically accepted evolution. Since only the most simi-
lar GenBank-catalogued sequence was retained for each species
included in this study, there is only a modest risk of accidental
selection of a paralogue instead of an orthologue. It is importantto note that the aggregate PBS values for these different nodes
were low and may be subject to topologic changes with the addi-
tion of more partitions. However, these ‘‘alternative’’ placements
of certain primate species in the SA tree might also be explained
by a reversion to an ancestral state for a particular disease gene.
In this instance, the ‘‘state’’ is the pattern of interaction between
the disease genes included in the study – the SA trees can be
thought of as a phylogenetic analysis of the possible network in
which some of the AD genes may function, and placement on the
tree represents nonspeciﬁc alterations to that network. Likewise,
an ‘‘ancestral state’’ is the structure and genetic landscape of this
possible network in a common ancestor to the organisms on the
tree. Therefore, this type of deviation from taxonomic evolution
represents potential evolutionary divergence of this theorized Alz-
heimer Disease gene network within isolated species. The presence
of these types of alternate evolutionary patterns suggests a poten-
tial differential susceptibility of species in the development of AD.
For example, the APBB2 and APP PBS values at node 13 in the
nucleotide SA tree (Table 3, emphasized in bold font) are
(i) Sorl1
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tively (compared to average values of 131.4 ± 620.1). These values
suggest a potential interaction (based on a strongly corroborated
evolutionary history) between the protein products of APBB2 and
APP in primates. Building on the known interaction between
APBB2 and APP in H. sapiens, exploration of the polymorphisms
in these genes in M. mulatta and O. garnettii may elucidate the
potential for differences in functional interactions. Such further
exploration of these types of ﬁndings, especially relative to critical
synapomorphic characters, could therefore yield valuable data
regarding the evolutionarily important functional or potentially
interacting sites for a given disease gene.
The individual data partition protein trees had a high incidence
of polytomy, which is when more than two species branch off of a
single node. This is generally considered uninformative in deter-
mining ancestry, as there are not enough data to determine
whether species branching off of the same node are more or less
closely related. However, these observations highlight the evolu-
tionary conservation of fundamental protein sequences over manyrelated organisms [61–65]. APP, one of the central genes in Alzhei-
mer Disease research, displays the most drastic examples of poly-
tomy, with 17 branches underneath one node alone (Fig. 3d, node
emphasized with red arrow). This reinforces previous studies
showing a high degree of conservation of the APP gene family over
time [66–70].
While the protein phylogenies demonstrate conservation of
structure across multiple species, the nucleotide sequences gener-
ate trees allowing a more precise elucidation of ancestry. Since
nucleotide sequences can have differences that do not affect pro-
tein structure or function due to the degeneracy of the genetic
code, rates of change in nucleotide sequences are more closely tied
to evolutionary time [49,71–73]). Among the individual partition
nucleotide trees, only the APBB2 tree has an occurrence of more
than two branches rooted at a single parent node. The branch gen-
erated at this node contains four species of very closely related
great apes (Nomascus leucogenys, Gorilla gorilla gorilla, Pan troglo-
dytes, and Pan paniscus – Fig. 2c, highlighted in yellow). This sug-
gests that the nucleotide sequences corresponding to APBB2 in
Fig. 4. Simultaneous analysis tree based on nucleotide data for included Alzheimer Disease genes. The tree is constructed by concatenating all nucleotide data partitions, and
SA support values are labeled at individual nodes to demonstrate how well each data partition corroborates the tree topology at that node. It should also be noted that this
tree follows commonly accepted evolutionary patterns more closely than most single-gene trees. Values at nodes are in the format x[y], where x is the Branch Score (BS) for
that node, and y is a unique identiﬁer (‘‘node number’’) corresponding to a row in Table 3, containing Partitioned Bremer Scores (PBS) for each nucleotide data partition
corresponding to the given node on the simultaneous analysis tree. Yellow highlighted region emphasizes paraphyly of primates (which are shown in red font) (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.).
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genetic relationship between them cannot be determined, which
underscores the fact that APBB2 is highly conserved among closely
related species.
Determination of the distance between individual trees prior to
constructing a consensus tree can help to preliminarily identify
clustering patterns among speciﬁc genes prior to constructing a
consensus tree [74]. Additionally, once a consensus is reached, the-
se distances can be used to explain the strength of the support for
the SA tree and generate representations of the gene network [75].
While multiple methods may be used to evaluate the distance
between trees consisting of the same set of taxa, this study used
the Robinson–Foulds (RF) distance [43]. The RF distance between
two trees is deﬁned by the sum of the number of data partitions
implied by one, but not both, of the trees. A variety of algorithms
exist for computing RF distance [76,77], and an optimal methodis usually selected on the basis of algorithmic complexity and
worst-case running time [51,78,79]. In this study, a gene network
was constructed based on tree topology similarity using RF (trans-
formed to RF0, which converts RF values onto a scale where higher
values correspond to less similarity).
On examination of the gene network for the Alzheimer Disease
genes used in this study (Figs. 2 and 3), a tight clustering of oxida-
tive stress genes was observed with the gene for plasminogen acti-
vator (PLAU) and a member of the sortilin related receptor gene
family (SORL1). While SORL1 has been found to have an important
association with Alzheimer Disease and oxidative stress genes are
involved in the unfolded protein response associated with
increased amyloid formation, a relationship between these genes
has not been shown before [80,81]. This type of association is not
observable using single pathway experiments or phylogenetic
methods that do not incorporate an SA approach. Further
Fig. 5. Simultaneous analysis tree based on protein data for included Alzheimer Disease genes. The tree is constructed by concatenating all protein data partitions, and SA
support values are labeled at individual nodes to demonstrate how well each data partition corroborates the tree topology at that node. It should also be noted that this tree
follows commonly accepted evolutionary patterns more closely than most single-gene trees, and polytomies are likewise eliminated. Values at nodes are in the format x[y],
where x is the Branch Score (BS) for that node, and y is a unique identiﬁer (‘‘node number’’) corresponding to a row in Table 4, containing Partitioned Bremer Scores (PBS) for
each protein data partition corresponding to the given node on the simultaneous analysis tree. Yellow highlighted regions emphasize division of primates into two clades, and
green highlighted region shows two species that might be considered possible model organisms for AD. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
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tering within the gene network.
In interpreting the SA values and the gene-clustering network
diagrams, two important assumptions regarding network medicine
and complex genetic disorders should be noted: (1) Althoughmany
genetic components may be identiﬁed for a given disease, it should
not be assumed that all of these factors are involved in the same
pathway – there may be multiple pathways involved; and (2) Co-
evolution of genes does not necessarily imply conservation due
to related function, and vice versa – co-evolution may be a result
of factors as simple as two genes being in close proximity on the
same chromosome. These assumptions underscore how the infor-
mation provided by SA techniques and the broader disease impli-
cations may be potentially misleading or incomplete.Nevertheless, an SA methodology might still provide insights to
potential targets for clinical therapies that would not have been
highlighted using more traditional single-gene based analytic
approaches.
A ﬁnal aspect of this study is that it further highlights the fact
that choice of model organism is paramount for the study of com-
plex disease. The relatively short lifespan of M. musculus and mal-
leability of the murine genome has led to an explosion of
experimental approaches centered on manipulation of genes
thought to be involved in human disease [82,83]. However, espe-
cially with relation to complex diseases, alternative model organ-
isms need to be considered [84]. The recent increase in biological
systems data and continued growth in bioinformatics methodolo-
gies for analyzing these data may allow for the development of
Table 3
Nucleotide PBS values for each internal node on nucleotide simultaneous analysis tree for each data partition. Node numbers are ASAP2 assigned labels, reported next to BS score
on SA tree (Fig. 4). Values for apbb2 and app gene partitions at node 13 are emphasized in bold due to their values being signiﬁcantly higher than other partitions at that node.
Node apbb2 nos3 plau sorl1 a2m blmh mpo ace app
1 1929 188 788 2136 111 775 54 134 305
2 457 173 21 604 197 493 49 1634 68
3 360 175 46 739 203 874 45 128 142
4 360 175 46 739 203 874 45 128 142
5 2 52 844 505 181 435 101 368 205
6 2 52 844 505 181 435 101 368 205
7 771 9 5 1414 231 897 34 25 67
8 1748 209 1283 1781 31 538 200 347 267
9 360 175 46 739 203 874 45 128 142
10 771 9 5 1414 231 897 34 25 67
11 46 197 1889 772 103 529 141 370 436
12 830 42 27 1570 138 1040 510 339 1607
13 993 110 152 343 179 1005 57 274 986
14 133 14 21 76 38 1942 366 223 1116
15 950 627 1229 1429 568 554 365 452 191
16 133 14 21 76 38 1942 366 223 1116
17 133 14 21 76 38 1942 366 223 1116
18 138 1203 23 80 39 1989 368 211 1094
19 360 175 46 739 203 874 45 128 142
20 771 9 5 1414 231 897 34 25 67
21 771 9 5 1414 231 897 34 25 67
22 771 9 5 1414 231 897 34 25 67
23 1216 158 757 1448 176 69 19 21 47
24 268 300 21 552 35 1 5 40 223
25 1086 348 2094 781 267 622 173 183 107
26 360 175 46 739 203 874 45 128 142
27 360 175 46 739 203 874 45 128 142
28 36 7 35 63 10 22 1 22 35
29 360 175 46 739 203 874 45 128 142
30 360 175 46 739 203 874 45 128 142
31 109 1 45 502 60 522 152 140 126
Table 4
Protein PBS values given for each internal node on protein simultaneous analysis tree for each data partition. Node numbers are ASAP2 assigned labels, reported next to BS score
on SA tree (Fig. 5).
Node apbb2 nos3 plau sorl1 a2m blmh mpo ace app
1 6 10 12.5 1 4.5 4 3.5 13.5 3
2 265 0 37 11 131 6 10 69 0
3 263 6 28 16 112 8 7 56 19
4 0 13 3 4 1 0 3 2 0
5 261 1 38 11 131 7 12 62 0
6 273 6 15 18 89 1 14 49 5
7 2 1 0 3 5 3 1 1 1
8 0 3 10 2 14 2 7 31 39
9 3 1 25 21 61 583 13 581 186
10 27 1 5 6 16 2 8 15 16
11 0 7 0 0 1 3 12 1 0
12 0 548 0 0 2 0 12 0 18
13 1 3 0 13 4 0 3 2 0
14 4 1 0 9 17 1 1 12 2
15 2 3 2 5 7 1 6 9 1
16 13 6 3 11 24 5 13 14 1
17 4 3 8 9 18 2 7 6 0
18 3 1 1 6 4 2 1 2 17
19 3 1 1 6 4 2 1 2 17
20 16 10 7 20 40 7 2 27 5
21 16 10 7 20 40 7 2 27 5
22 3 1 25 21 61 583 13 581 186
23 16 10 7 20 40 7 2 27 5
24 4 2 1 0 4 2 0 5 2
25 21 5 5 16 12 1 8 10 2
26 30 4 14 1 24 909 160 571 176
27 2 6 2 3 5 3 1 7 1
28 2 13 1 3 4 8 15 33 40
29 12 27 31 42 120 7 90 68 334
30 2 13 1 3 4 8 15 33 40
31 3 1 25 21 61 583 13 581 186
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For example, based on the preliminary ﬁndings of this study of the
shared evolution of a limited set of genes thought to inﬂuence ADsusceptibility in humans, the SA consensus trees suggest that S.
scrofa (pig) and J. jaculus (jerboa) may be more suitable model
organisms than murine species (Fig. 5, highlighted in green).
Table 5
ILD and RF0 distance between each pair of AD trees for nucleotide sequence data partitions. Unshaded cells show ILD conﬁdence interval (p-value: lower numbers indicate higher
degree of incongruity), and shaded cells show RF0 distances. Values are unitless. Lower RF0 values are indicative of higher similarity between trees. Using this implementation of
the Robinson–Foulds algorithm, values should only be quantitatively compared within the same table – scale varies based on the speciﬁc analysis.
Table 6
ILD and RF0 distance between each pair of AD trees for protein sequence data partitions. Unshaded cells show ILD conﬁdence interval (p-value: lower numbers indicate higher
degree of incongruity), and shaded cells show RF0 distances. Values are unitless. Lower RF0 values are indicative of higher similarity between trees. Using this implementation of
the Robinson–Foulds algorithm, values should only be quantitatively compared within the same table – scale varies based on the speciﬁc analysis.
Table 7
RF and RF0 values between corresponding nucleotide and protein trees for each gene.
Values are unitless. Higher RF values (and lower RF0 values) are indicative of higher
similarity between trees. Using this implementation of the Robinson–Foulds
algorithm, values should only be quantitatively compared within the same table –
scale varies based on the speciﬁc analysis.
Gene RF RF0
APBB2 0.880 0.415
NOS3 0.593 0.553
PLAU 0.714 0.490
SORL1 0.900 0.407
A2M 0.559 0.572
BLMH 0.770 0.463
MPO 0.367 0.693
ACE 0.900 0.407
APP 0.837 0.433
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Similar to how phylogenetic analyses can be difﬁcult to fully
validate, since a given phylogenetic analysis is often perceived as
a hypothesis, the evaluation of SA techniques can be difﬁcult. Fur-
ther challenging the validation of the approach presented here is
the paradigm shift of identifying potential co-evolutionary rela-
tionships relative to a complex disease. The validation of the
approach developed in this study was thus done by examining
the characteristic of a gene network developed from two types of
genes: (1) those that have been known to have co-evolved (a posi-
tive control; should cluster); and, (2) a random selection of disease
genes that have not been described in a co-evolutionary context
(negative control; should not cluster).
Based on the premise that mitochondrial genes evolve at a dis-
tinguishable rate between different species (implying that phylo-
genetic analyses of mtDNA genes often recapitulate taxonomy)
[85,86], this study explored whether the AD gene clustering might
be meaningful relative to taxonomy (thus implying evolutionaryconservation of clustered genes). This strategy for benchmarking
the ASAP2 analysis of AD genes using mitochondrial DNA
sequences reinforces the principle that SA techniques may be used
to study deviations in evolutionary conservation among isolated
genes. In this study, ASAP2 revealed that the included mitochon-
drial genes showed a pattern of clustering (based on RF0 values)
that was highly similar to the clustering of a subset of AD genes
that could potentially be involved in previously unpredicted rela-
tionships via metabolic stress pathways. While this does not
deﬁnitively prove that a causal relationship exists between the
aforementioned AD genes, it does demonstrate that ability of
ASAP2 to highlight possible relationships of interest for complex
disease genes that might warrant further investigation.
By contrast, genes that operate in different metabolic and struc-
tural protein pathways are not likely to have many strong func-
tional links between the genes associated with other disease
related pathways [87]. The SA analysis and resultant gene network
of the eight randomly selected disease genes did not show any
apparent clustering, especially relative to either the AD genes or
the mtDNA genes. The results of this second benchmark support
the implied corollary to the hypothesis of this study: Strongly dis-
similar patterns of evolutionary conservation emerge when com-
paring phylogenetic analyses of genes that are not closely related
or not likely to interact with one another. In sequence, this
strengthens the premise that simultaneous analysis may yield a
new type of information that is rooted in tangible, evolutionarily
signiﬁcant (and potentially yet undiscovered) pathophysiological
events.
The results of this study suggest that SA techniques can provide
metrics that complement network medicine approaches that have
been used to explore disease genes. For example, the resulting gene
network from this study can be used to further add structure to the
Diseasome [88], which is a network of disease genes that are ascer-
tained from inferred relationships as reported in OMIM. To this
point, the tightest cluster of genes observed in the SA-based gene
network developed in this study (A2M, PSEN2, APBB2, PLAU,
NOS3
APBB2
A2M
BLMH
MPO
APP
SORL1
ACE
PLAU
APP
SORL1
NOS3
BLMH
APBB2
A2M
PLAU
ACE
MPO
(a)
(b)
Fig. 6. Clustering of Alzheimer Disease gene sequences based on similarity of tree topology. Based on clustering based on tree topology similarity for nucleotide (a) and
protein (b), the graphs reveal a tight clustering of the A2M, MPO, PLAU, and NOS3 genes. This suggests that these genes may have a shared evolutionary history and thus may
infer a yet-uncharacterized functional association related to the AD phenotype. Clustering of genes with most common evolutionary patterns are identiﬁed using gray
ellipses. Nodes on the graph represent individual nucleotide gene partitions, and connecting edges are relative distances between trees, represented numerically as RF0 values
(shorter edges correspond to more highly similar trees). RF0 values are listed in Table 5. RF0 is unitless.
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Disease (i.e., they have no other disease connections in the Disea-
some); the two genes that are observed as having slightly less cor-
relation (APP and ACE) are linked with other diseases (APP with
Schizophrenia and Amyloidosis; and, ACE with Renal Tubular
Dysgenesis, Progression of SARS, and Myocardial Infarction). The
results of this study therefore suggest that, in addition to the
uniqueness that has been shown by the Diseasome, there is a
strong correlative history of these genes. ASAP2 thus offers anevolutionary framework by which one might study disease genes
that can further warrant concurrent investigation of putatively
associated genes relative to a shared disease phenotype.
4.5. Identifying new complex disease genes relationships using ASAP2
The AD genes selected for use throughout this study were iden-
tiﬁed from previous investigations. ASAP2 was designed to take a
known set of related genes and compare their gene genealogies
Table 8
Randomly selected genes for negative control benchmark, with corresponding
complex genetic disorder(s) included. GenBank/GenPept query GIs for each gene
are available in Supplementary Data.
Gene Common name Complex disease
abcc8 Sulfonylurea Receptor Type 2 Diabetes
mellitus
adrb2 Beta-2-Adrenergic Receptor Obesity/Asthma
app Amyloid-b Precursor Protein Alzheimer Disease
brca2 Breast Cancer Type 2 Susceptibility Protein Various cancers
park2 Parkin Parkinson Disease
ldlr Low Density Lipoprotein Receptor Hypercholesterolemia
calcr Calcitonin Receptor Osteoporosis
nod2 Nucleotide-Binding Oligomerization
Domain Protein 2
Inﬂammatory Bowel
Disease
 Also in AD analysis.
Table 9
RF and RF0 distance between each pair of second benchmark trees for nucleotide
sequence data partitions. Unshaded cells show RF distances, and shaded cells show
RF0 distances.
Table 10
RF and RF0 distance between each pair of second benchmark trees for protein
sequence data partitions. Unshaded cells show RF distances, and shaded cells show
RF0 distances.
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selves apparent. The strong segregation of AD genes in the context
of including a random set of complex disease genes in ASAP2 sug-
gests that if a number of genes for a given complex disease cluster
together, other genes within that cluster may be related to the
given complex disease. Although this does not in any way abso-
lutely conﬁrm that relationships between putatively related dis-
ease genes exist, it provides a target for future studies that can
aim to resolve potential relationships.
The originally described method provides a forward genetics
approach to complex diseases (i.e., identifying genotypic function-
ality from phenotype data), while the retooling of ASAP2 could be
described as a reverse genetics approach – starting with widely
distributed genomic data and linking a phenotype to a subset of
those data. In consort, these two approaches to using ASAP2 (and
similar such tools) could deﬁne a highly effective means of resolv-
ing the array of incongruities that are often observed between
genotypic (genomic) and phenotypic (complex disease) data
sources, eventually deﬁning new therapies and treatments for
diseases.The orthologous genes and their associated taxa were chosen
using a strictly bioinformatics approach; there was no a priori
selection of taxa that represent speciﬁc phenotypes (e.g., those that
exhibit characteristics of AD similar to human manifestation of the
condition) or to ensure complete taxonomic representation.
Instead, the approach was chosen to include all available data
based solely on a stringent sequence similarity criterion. For trans-
lational utility, it would be essential for future studies to include
some selection of taxa that represent different observable pheno-
types and then seek to identify patterns of evolution that may con-
note protective or causative genetic characteristics. Additionally,
further validation of the approach presented in this study will
undoubtedly require the veriﬁcation of its applicability for other
complex diseases. This will be essential to resolve the potential
issue that the gene network characteristics observed in this study
may be unique to Alzheimer Disease. Future work will thus be
focused on the application of ASAP2 in the context of other com-
plex diseases, including those that have been characterized in the
Diseasome. It is important to consider that the identiﬁcation of
orthologues across multiple genes for multiple diseases for the
same set of taxa is a formidable challenge. Because of an artifact
that AD disease genes are heavily studied, it was possible for
ASAP2 to easily identify orthologues (based on a strict sequence
similarity cut-off) for 34 taxa. However, it was not possible to read-
ily identify another set of orthologues for another disease for the
same 34 taxa. A signiﬁcant future enhancement of the SA approach,
therefore, would require either the accommodation of different
sets of taxa across different diseases or identiﬁcation of a core
set of taxonomically diverse taxa that can be used across all the
diseases of interest. The identiﬁcation of taxa that are missing
orthologous gene sequences could also be used to guide future
molecular sequencing efforts.
5. Conclusion
Phylogenomic studies using simultaneous analysis techniques
are positioned to become more commonplace as increasing
amounts of genomic data are available across the spectrum of life
and systematically available through resources such as GenBank.
Here, an automated tool (ASAP2) is presented with the intent of
enabling researchers to leverage these data to support studies that
aim to unveil potentially evolutionarily signiﬁcant relationships
that can complement other network approaches. The application
of ASAP2 to a set of nine genes associated with Alzheimer Disease
demonstrated a potentially important clustering of genes that cor-
roborates other network approaches, and also suggests that there
may be an evolutionarily meaningful reason for their correlation
with the Alzheimer Disease phenotype. The results thus suggest
that the methodology presented here may be used to add addition-
al, evolutionarily informed structure to gene network studies.
Appendix A. Supplementary material
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.jbi.2015.01.002.
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